Question 1

What is André Choulika?

Accepted Answer

André Choulika is a Person.

Question 2

How often does André Choulika appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was André Choulika first tracked by Ergen?

Accepted Answer

First tracked on Jun 09, 2026.

Question 4

When was André Choulika last mentioned in news?

Accepted Answer

Last active on Jun 09, 2026.

Question 5

What is André Choulika's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is André Choulika in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving André Choulika?

Accepted Answer

Cellectis lasme-cel receives FDA RMAT (Jun 09, 2026, 6 articles).

Question 8

How did the "Cellectis lasme-cel receives FDA RMAT" event impact André Choulika?

Accepted Answer

André Choulika, Co-founder and CEO of Cellectis>>>, commented on the significance of the RMAT designation for Cellectis>>>'s pioneering work in allogeneic CAR-T therapies.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.